术前口服补液盐联合硫酸镁对老年乳腺癌根治术患者C-反应蛋白、GFV及预后的观察

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (595 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨术前口服补液盐联合硫酸镁对老年乳腺癌根治术患者C-反应蛋白（CPR）、胃内容物残留量（GFV）及预后的观察。方法选择2018年11月—2019年4月河北北方学院附属第一医院择期实施乳腺癌根治术的患者80例，按照随机数字表法将其分为联合组、硫酸镁液组，每组各40例。硫酸镁液组术前1 d 15∶00口服25%硫酸镁液50 mL。联合组术前1 d 15∶00口服25%硫酸镁液50 mL，17∶00口服补液盐，溶于300 mL温开水中，1 h内服完。统计两组术前1 d 8∶00（T1）和手术当日8∶00空腹时（T2）CRP水平和术前1 d 14∶00（T3）和术前1 d 23∶00时（T4）GFV；统计两组在给予硫酸镁液后至手术当日8∶00时排便次数以及术后排气时间和术后住院时间；采用视觉模拟评分法（VAS）统计两组入室静息状态（T5）、手术结束即刻（T6）和术后1 d（T7）时VAS评分，比较两组术后不良反应发生情况。结果与T1时点比较，两组T2时点CRP水平均降低，且T2时点联合组CRP水平低于硫酸镁液组，差异均有高度统计学意义（均P ＜ 0.01）。与T3时点比较，两组T4时点GFV均减少，且T4时点联合组低于硫酸镁液组，差异均有高度统计学意义（均P ＜ 0.01）。联合组排便次数高于硫酸镁液组，术后排气时间、术后住院时间短于硫酸镁液组及术后不良反应发生率低于硫酸镁液组，差异均有统计学意义（均P ＜ 0.05）。联合组于T7时VAS评分低于硫酸镁液组，差异有统计学意义（P ＜ 0.05）。结论术前口服补液盐联合硫酸镁可以降低老年乳腺癌根治术患者术前CRP水平和GFV，减少术后不良反应发生率，值得在临床中推广应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	訾聪娜樊娟邢珍

关键词 ：乳腺癌, 硫酸镁, 补液盐, C-反应蛋白

Abstract：Objective To investigate the effect of preoperative oral rehydration salts combined with magnesium sulfate on C-reactive protein (CPR) and residual gastric fluid volume (GFV) and prognosis in elderly breast cancer patients undergoing radical mastectomy. Methods Eighty patients undergoing radical mastectomy in the First Affiliated Hospital of Hebei North University from November 2018 to April 2019 were selected and divided into the combined group and the magnesium sulfate solution group according to the random number table method, with 40 cases in each group. In the magnesium sulfate solution group, 50 mL of 25% magnesium sulfate solution was taken orally at 15∶00 one day before operation. The combined group was given 50 mL of oral 25% magnesium sulfate solution at 15∶00 on one day before operation and oral rehydration salt at 17∶00, dissolved in 300 mL warm water, and was taken within one hour. The levels of CRP at 8∶00 on one day before operation (T1) and fasting at 8:00 on the day of operation (T2) were calculated, as well as GFV at 14∶00 on one day before operation (T3) and 23∶00 on one day before operation (T4). The times of defecation, postoperative exhaust time and postoperative hospital stay of the two groups were counted from 8∶00 on the day of operation after magnesium sulfate solution was given. Visual analogue scales (VAS) was used to calculate the VAS scores of the two groups at the room resting state (T5), immediately after surgery (T6) and one day affer surgery (T7). The occurrence of postoperative adverse reactions was compared between the two groups. Results Compared with T1 time point, the levels of CRP were decreased in both groups at T2 time point, and the combined group was lower than that in the magnesium sulfate solution group at T2 time point, the differences were highly statistically significant (all P ＜ 0.01). Compared with T3 time point, GFV in both groups was reduced at T4 time point, and the combined group was lower than magnesium sulfate solution group at T4 time point, the differences were highly statistically significant (all P ＜ 0.01). The times of defecation in the combined group was higher than that in the magnesium sulfate solution group, and the postoperative exhaust time and postoperative hospital stay were shorter than those in the magnesium sulfate solution group, and postoperative adverse reactions were lower than that in the magnesium sulfate solution group, with statistically significant differences (all P ＜ 0.05). VAS score in T7 of the combined group was lower than that of the magnesium sulfate solution group, and the difference was statistically significant (P ＜ 0.05). Conclusion Preoperative oral rehydration salts combined with magnesium sulfate can reduce the preoperative the levels of CRP and GFV in elderly breast cancer patients and reduce the incidence of postoperative adverse reactions, which is worthy of clinical application.

Key words： Breast cancer Magnesium sulfate Rehydration salts C-reactive protein

基金资助:河北省卫生健康委员会办公室医学科学研究课题计划项目（20190889）。

通讯作者: 邢珍（1968.11-），女，硕士，主任医师，教授，硕士研究生导师，河北北方学院附属第一医院麻醉科副主任；研究方向：心脏手术麻醉。

作者简介: 訾聪娜（1980.12-），女，硕士；研究方向：心脏病人非心脏手术麻醉，老年患者和小儿患者麻醉。

引用本文:

訾聪娜樊娟邢珍. 术前口服补液盐联合硫酸镁对老年乳腺癌根治术患者C-反应蛋白、GFV及预后的观察[J]. 中国医药导报, 2020, 17(26): 95-98.
ZI Congna FAN Juan XING Zhen. Observation of preoperative oral rehydration salts combined with magnesium sulfate on C-reactive protein, GFV and prognosis of elderly breast cancer patients undergoing radical mastectomy. 中国医药导报, 2020, 17(26): 95-98.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2020/V17/I26/95

[1] Bulkowska M，Rybicka A，Senses KM，et al. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours [J]. BMC Cancer，2017，17（1）：728.
[2] 罗娅红.乳腺癌的影像学诊断进展和研究方向[J].中国医学影像技术，2017，33（5）：645-646.
[3] Harper KL，Sosa MS，Entenberg D，et al. Corrigendum：Mechanism of early dissemination and metastasis in Her2+ mammary cancer [J]. Nature，2018，553（7688）：366.
[4] 刘子梅，沈赞.三阴性乳腺癌靶向治疗最新进展[J].中国癌症杂志，2017，27（1）：36-40.
[5] 庄心良，曾因明，陈伯銮.现代麻醉学[M].3版.北京：人民卫生出版社，2003.
[6] 郭曲练，姚尚龙.临床麻醉学[M].4版.北京：人民卫生出版社，2016.
[7] 王鹤玮，贾杰.乳腺癌术后上肢淋巴水肿的检查与评估研究进展[J].中国康复理论与实践，2017，23（9）：1001-1006.
[8] Rifai N，Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening [J]. Clin chem，2001，47（1）：28-30.
[9] 郭政，王国年.疼痛诊疗学[M].4版.北京：人民卫生出版社，2016.
[10] Harris EER，Small W. Intraoperative Radiotherapy for Breast Cancer [J]. Front Oncol，2017（7）：317-345.
[11] Nayyar A，Gallagher KK，McGuire KP. Definition and Management of Positive Margins for Invasive Breast Cancer [J]. Surg Clin North Am，2018，98（4）：761-771.
[12] 李谦，王建荣.老年患者结肠镜检查前肠道准备对肠道清洁度及耐受度的影响[J].现代消化及介入诊疗，2017， 22（3）：407-410.
[13] 王涛.谷氨酰胺与低渗口服补液盐联合治疗小儿腹泻的效果分析[J].山西医药杂志，2016，45（11）：1247-1249.
[14] 张苏棉，王利利，郭小丽.干扰素雾化联合口服补液盐治疗疱疹性咽峡炎的疗效研究[J].检验医学与临床，2017，14（10）：1407-1409.
[15] 胡艳杰，李卡，李立，等.术前机械性肠道准备对结肠癌患者早期康复疗效的影响：随机对照研试验[J].南方医科大学学报，2017，37（1）：13-17.
[16] 杨祯玲，赵妙，黄七任，等.结肠镜术前应用西甲硅油的效果分析[J].中国内镜杂志，2017，23（4）：26-29.
[17] 潘荟丞，陈荣花，刘建荣，等.星状神经节阻滞治疗乳腺癌化疗性静脉炎性痛的疗效[J].中国肿瘤临床与康复，2016，22（12）：1501-1504.
[18] Karuturi MS，Holmes HM，Lei X，et al. Potentially inappropriate medication use in older patients with breast and colorectal cancer [J]. Cancer，2018，124（14）：3000-3007.
[19] Karuturi MS，Holmes HM，Lei X，et al. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer [J]. J Geriatr Oncol，2019，10（5）：705-708.
[20] 何干，陈凯，刘洋，等.结直肠择期手术前机械性肠道准备必要性的Meta分析[J].中国老年学杂志，2017，37（8）：1959-1962.
[21] Dent R，Trudeau M，Pritchard KI，et al. Triple-negative breast cancer：clinical features and patterns of recurrence [J]. Clin Cancer Res，2007，13（15 Pt 1）：4429-4434.
[22] 訾聪娜，樊娟，李艳明，等.术前口服补液溶液对乳腺癌根治术患者术后康复进程及预后的影响[J].中国医药导报，2019，16（34）：112-116.
[23] 訾聪娜，马先，滕金亮，等.甘露醇联合口服补液盐对老年乳腺癌根治术患者术后肠功能恢复情况及肠道清洁度的影响[J].中国医药，2020，15（4）：569-572.
[24] Itoh S，Arai M，Kuroiwa M，et al. Effect of Preoperative Oral Rehydration on the Hypotension during Spinal Anesthesia [J]. Masui，2016，65（8）：786-789.
[25] Shah JN，Maharjan S，Gurung R. Shortened Preoperative Fasting Time to Allow Oral Rehydration Solution Clear Liquid up to Two Hours before Elective Major Surgery in Adults [J]. J Coll Physicians Surg Pak，2018，28（5）：348-351.
[26] 丁献菊，王诗语，李春丽.短肽型肠内营养制剂在妇科腹腔镜术前肠道准备中的应用[J].肠外与肠内营养，2017，24（4）：229-232.
[27] Subramaniam P，Girija P，Eswara U，et al. Oral rehydration salt-liquid as a storage medium for avulsed tooth [J]. Dent Traumatol，2015，31（1）：62-66.